Co-Diagnostics

+$0.53 (+10.66%) Today
+$0.02 (+0.36%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Co-Diagnostics and other ETFs, options, and stocks.

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

CEO
Dwight Howard Egan
Employees
101
Headquarters
Salt Lake City, Utah
Founded
2013

CODX Key Statistics

Market cap
186.93M
Price-Earnings ratio
3.82
Dividend yield
—
Average volume
537.63K
High today
$5.89
Low today
$4.95
Open price
$4.99
Volume
2.77M
52 Week high
$11.82
52 Week low
$3.66

CODX News

MarketWatchMay 26

Co-Diagnostics Shares Rise 10% After Completing Principal Design of Test for Monkeypox Virus - MarketWatch

By Chris Wack Co-Diagnostics Inc. shares were up 10% to $5.07 after the company said it has completed the principal design work of a PCR test for the monkeypox

CODX Earnings

$0.00
$0.21
$0.42
$0.63
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure